Genetics and epigenetics

Transcriptomic analysis may help predict the survival rate of Ebola patients

CRISPR is the new kid on the block, but do ZFNs and TALENs still have a place?

Vassilis Gorgoulis, Director of the Laboratory of Histology-Embryology, National and Kapodistrian University of Athens

Growing demand for multiple biomarker analysis gives diagnostics labs new challenges

Precision medicine’s focus on the genome may be blinding us to vital non-genomic tools

CAP, ASCP, and ASCO issue joint HER2 guidelines for gastroesophageal adenocarcinoma

With intellectual and metabolic differences, sequencing can aid diagnosis and treatment

A recent study says precision medicine really does make a difference in cancer care

Alejandro Madrigal, Scientific Research Director at Anthony Nolan, London, UK

Genomic and proteomic testing at diagnosis can speed up treatment for cancer patients